Alzheimer News: Breaking Alzheimer News, Comments and Articles.

Amarantus Reports Positive Results on MANF Neuroprotective Properties Demonstrated in Preclinical Study in China

Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, announces that positive neuroprotective properties for the Company’s MANF therapeutic were reported in a preclinical research study conducted by the Department of Or...

New Charity Foundation Will Give Specialized Care for Individuals with Alzheimer’s

The Memory Loss Foundation has launched its official charity to help improve the lives of seniors living with dementia. Toronto, ON (PRWEB) June 19, 2013 Dementia/Alzheimer’s has plagued many of our senior population. Family members are left with little choices to care for their loved ones who are suffering from this disease. The numbers are quickly increasing, and no new medications have been...

Perispinally Administered Enbrel Facilitates Rapid Recovery of Cognitive Function in Patients with Alzheimer's

Newly published research by the prestigious Dana Foundation elucidates the operational mechanisms enabling the restoration of mental faculties. NWC physicians applaud the Dana Foundation's contribution to understanding the role neuro-inflammation plays in the pathogenesis of Alzheimer's disease. (PRWEB) June 19, 2013 Pharmaceutical history is replete with examples of drugs being utilized...

Lipidation states in certain proteins in the brain differ depending on genotype, cognitive diseases

The lipidation states (or modifications) in certain proteins in the brain that are related to the development of Alzheimer disease appear to differ depending on genotype and cognitive diseases, and levels of these protein and peptides appear to be in...

Discovery Of Rare Genomic Mutations In 10 Families With Early-Onset, Familial Alzheimer's Disease

Although a family history of Alzheimer's disease is a primary risk factor for the devastating neurological disorder, mutations in only three genes - the amyloid precursor protein and presenilins 1 and 2 - have been established as causative for inheri...

Memory Loss In Alzheimer's Recovered By Blocking Overactive Receptor

A new study shows that memory pathology in older mice with Alzheimer's disease can be reversed with treatment. The study by researchers from the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and at Université de Mo...

New Drug Developed That Reverses Loss Of Brain Connections In Alzheimer's

The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destruct...

Acat1 Knockdown Gene Therapy Decreases Amyloid-β in a Mouse Model of Alzheimer’s Disease

The NIH Aims To Develop Drugs That Big Pharma Discarded

This morning, the National Institutes of  awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer’s disease, Duchenne muscular dystrophy, and schizophrenia that drug companies had abandoned be...

High-Fat Diet Could Interrupt Amyloid Clearance

Study uncovers possible mechanism by which a diet high in saturated fat might disrupt the key process that clears amyloid from the brain, thereby raising risk for Alzheimer's disease. Medscape Medical News

Aricept Helps Cognition in Parkinson's (CME/CE)

SYDNEY (MedPage Today) -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) with no detriment to their motor skills, researchers reported here.

Concussion patients show Alzheimer’s-like brain abnormalities

The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer’s dementia, according to a new...

Bon Secours New York Health System Promotes Dominic D’Ambrosio to Administrator at Schervier Nursing Care Center

Bon Secours New York Health System (BSNY) announces the promotion of Dominic D’Ambrosio to Administrator at Schervier Nursing Care Center, specializing in long-term and rehabilitation care in the Riverdale section of The Bronx. Riverdale, NY (PRWEB) June 18, 2013 Bon Secours New York Health System (BSNY) announces the promotion of Dominic D’Ambrosio to Administrator at Schervier Nursing Care...

T3D Licenses Drug Candidate from Dara, Repositions It for Alzheimer's

Using Altered Metabolic Pathways to Diagnose Alzheimers Disease

In previous notes, I have touched lightly on metabolomics but have not discussed the relevance of this science for clinical applications (see: Metabolomics, Metabolomic Profiling, and Systems Biology). A recent article made me more aware of some of t...

Blocking B1R receptor activity in brains of Alzheimer's mice recovers memory and cerebrovascular function

A new study shows that memory pathology in older mice with Alzheimer's disease can be reversed with treatment. The study by researchers from the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and at Universit- de Montr...

Study shows brain abnormalities in MTBI patients closely resemble Alzheimer's dementia

The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer's dementia, according to a new study published online in the journal Radiology.

Brain Inflammation Due To Obesity Compounded By Low Testosterone

Low testosterone worsens the harmful effects of obesity in the nervous system, a new study in mice finds. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. "Low testosterone and obesity are common in aging me...

MGH researchers discover CNVs in members of 10 families with early-onset Alzheimer's

Although a family history of Alzheimer's disease is a primary risk factor for the devastating neurological disorder, mutations in only three genes - the amyloid precursor protein and presenilins 1 and 2 - have been established as causative for inheri...

Concussion patients show Alzheimer's-like brain abnormalities

The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer's dementia, according to a new study published online in the journal Radiology.

DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959

RALEIGH, NC--(Marketwired - June 18, 2013) - DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology supportive care products, announced today that it has granted T3D Therapeutics, Inc. the exclusive worldwide rights to develop and commercialize DB959. DB959 is an oral, highly selective, dual nuclear receptor agonist whose primary target is PPARd (peroxisom...

NIH to fund collaborations with industry to identify new uses for existing compounds

(NIH/National Center for Advancing Translational Sciences (NCATS)) The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for...

A Protein Developed To Protect And Restore Nerve Cell Communications

A structure called "the microtubule network" is a crucial part of our nervous system. It acts as a transportation system within nerve cells, carrying essential proteins and enabling cell-to-cell communications. But in neurodegenerative diseases like...

Brain Abnormalities In People With Concussions Similar To Those With Alzheimer's

The layout of white matter brain abnormalities in people after traumatic brain injuries (mTBI) are similar to those found in early Alzheimer's, according to new research. The finding, published in Radiology, suggests that the first traumatic event th...

Cerebain Biotech Corp. Appoints Dr. Saini Chairman of Its Scientific Advisory Board

Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO) announced today the appointment of Dr. Surinder Saini as Chairman of its Scientific Advisory Board. The advisory board provides key clinical insight into the company’s efforts to develop and commercialize a novel approach to the tre...